Charlie Rose Season 20 Episode 148 Charlie Rose Brain Series 2: Schizophrenia

In season 20 episode 148 of Charlie Rose, the host continues his series on the topic of the brain, this time focusing on schizophrenia. Rose interviews a variety of experts in the field, including scientists, psychiatrists, and those who suffer from the disorder themselves.

The first guest is Dr. Elyn Saks, a law professor and author who has schizophrenia. Saks explains that the disorder is often misunderstood and stigmatized, and that it is not the same as multiple personalities. She discusses her own experiences with medication and therapy, and shares her thoughts on the importance of human connections and support in managing the illness.

Rose then speaks with Dr. Stephen Marder, a psychiatry professor at UCLA who has been studying schizophrenia for over 30 years. Dr. Marder explains that the disorder is characterized by symptoms such as hallucinations, delusions, and disorganized thinking. He also discusses the various treatments available, including medication and therapy, and emphasized the importance of early intervention.

Another guest, Dr. Daniel Javitt, a neuroscientist at Columbia University, discusses his research on the brain chemistry of schizophrenia. He explains that the disorder is caused by a disruption in the way that the brain processes certain chemicals, and that this disruption can be targeted by new medications currently in development.

Finally, Rose speaks with two individuals who have schizophrenia and have been able to manage their symptoms thanks to medication and therapy. Both guests emphasize the importance of finding a supportive community, as well as the importance of taking ownership of their treatment and advocating for their own needs.

Overall, this episode of Charlie Rose provides a comprehensive overview of schizophrenia and its treatment, with insights from both experts and those who have personal experience with the disorder. The episode seeks to break down stigmas and misunderstandings surrounding the disorder, and encourages early intervention and support as critical components of effective treatment.